DNA replication stress is a major source of genomic instability and is closely linked to 24 tumor formation and progression. Poly(ADP-ribose)polymerases1/2 (PARP1/2) 25 enzymes are activated in response to replication stress resulting in poly(ADP-ribose) 26 (PAR) synthesis. PARylation plays an important role in the remodelling and repair of 27 impaired replication forks, providing a rationale for targeting highly replicative cancer 28 cells with PARP1/2 inhibitors. The human oncoprotein DEK is a unique, non-histone 29 chromatin architectural protein whose deregulated expression is associated with the 30 development of a wide variety of human cancers. Recently, we showed that DEK is a 31 high-affinity target of PARylation and that it promotes the progression of impaired 32 replication forks. Here, we investigated a potential functional link between PAR and 33 DEK in the context of replication stress. Under conditions of mild replication stress 34 induced either by topoisomerase1 inhibition with camptothecin or nucleotide depletion 35 by hydroxyurea, we found that the effect of acute PARP1/2 inhibition on replication 36 fork progression is dependent on DEK expression. Reducing DEK protein levels also 37 overcomes the restart impairment of stalled forks provoked by blocking PARylation.
INTRODUCTION
measurements, STORM imaging buffer was used (prepared following Nikon's STORM 269 Protocol-Sample Preparation) containing GLOX solution as oxygen scavenging 270 system (40 mg/ml Catalase, Sigma; 0.5 mg/ml glucose oxidase; 10 % glucose in PBS) 271 and MEA 10 mM (Cysteamine MEA, Sigma-Aldrich, #30070-50G, in 360 mM Tris-HCl). 272 Single molecule localization and super-resolution image reconstruction were 273 performed using NIKON software (NIS elements) and a custom software (Insight3, Site-directed mutagenesis 280 Nucleobase mutations of the DEK primary sequence were introduced via a modified 281 Quick ChangeTM site-directed mutagenesis protocol [48] . To generate the DEK-GFP 282 template for the mutagenesis PCR, the DEK WT sequence was inserted into an eGFP 283 reporter plasmid (peGFP-N1, Addgene 6085-1). PAR-binding domain 2 (bases 583 -284 663) and the DEK shRNA target site (bases 1000 -1020) were mutated using 285 overlapping primer pairs containing the desired base changes. For the PAR-binding 286 domain a total of 9 codons were mutated in four rounds of mutagenesis (primers 287 PBD2-Part1-4, see also Fig 7 B ). For the shRNA target site a total of 8 nucleobases 288 were mutated in two rounds (primers shDEK-Part1-2), resulting in silent mutations and 289 diminished binding of the DEK shRNA. Primer sequences are listed in S1 Table. 290 Expression and purification of recombinant GST-tagged proteins 292 from E. coli 293 The mutated DEK sequence (DEK PBD2-Mut2) was inserted into a GST expression 294 plasmid. LBamp medium was inoculated with E.coli BL21(DE3) pGEX 4T-1 harbouring 295 plasmids encoding GST only, GST-DEK WT, or GST-DEK PBD2-Mut2. Protein Firstly, we examined the effect of DEK and PARP1/2 activity on CPT-induced 368 replication fork progression using DNA fiber assays (Fig 1) . Cells bearing a stable, 369 lentiviral mediated knockdown of DEK expression (shDEK cells) and the respective 370 control cells [43] were treated with 25 nM CPT in the presence and absence of ABT-371 888. Both drugs were added simultaneously with the IdU-containing medium (Fig 1 A) .
372
In line with our previous results, knockdown of DEK expression slowed down 373 replication fork progression per se as indicated by a highly significant reduction of the 374 IdU tract lengths in untreated shDEK cells as compared to controls (Fig 1 C and [43] ).
375
Inhibition of PARP1/2 activity with ABT-888 had no significant effect on replication fork 376 speed in both control and shDEK cells, measured as the ratio of the IdU-labelled tracts 377 (green) vs the CldU-labelled tracts (red) (Fig 1 D, compare boxes 1 and 2) . Notably, in all our PARP1/2 inhibition experiments, we took care of minimizing DNA damage 379 due to trapping of the enzyme on DNA [7] . Therefore, we used ABT-888 as an inhibitor 380 with reportedly low trapping activity and limited the exposure to the duration of the IdU-381 pulse. PARP1/2 activity is effectively inhibited under these conditions (S1 A, B Fig) but 382 does not trigger a DNA damage response, as indicated by the absence of 53BP1 foci 383 formation (S1 C, D Fig; see also [50, 51] ). 
